Study provides roadmap to more personalized cancer treatment

Posted by on December 22, 2016 5:04 pm
Tags:
Categories: health

People with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation, research has found.

Leave a Reply

Your email address will not be published. Required fields are marked *